Skip to content

Author

Tryfon Zarganes-Tzitzikas

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Chemical probes for Alzheimer's disease targets.

Developing compounds initially developed as potential therapies have provided valuable mechanistic insight, even where they did not translate into clinical benefit, underline the need for rigorous probe selection, validation, and experimental design in AD research.

Sheenagh G. Aiken, Tryfon Zarganes-Tzitzikas, Paul E. Brennan · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.